共 50 条
- [21] PREDICTIVE AND PROGNOSTIC SIGNIFICANCE OF TUMOR LOCATION IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH ANTI-PD-1 THERAPYCHEST, 2020, 157 (06) : 234A - 234ATakamori, S.Takada, K.Shimokawa, M.Matsubara, T.Haratake, N.Miura, N.Toyozawa, R.Yamaguchi, M.Takenoyama, M.Okamoto, I.Tagawa, T.Mori, M.
- [22] Anti-PD-1 Combination Therapy as Second Line Treatment or Beyond in Patients with Advanced Non-Small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1055 - S1055Zhang, F.Huang, D.Li, L.Ma, J.Wang, J.Jiao, S.Hu, Y.
- [23] The peripheral CD4+ T cells predict efficacy in non-small cell lung cancer (NSCLC) patients with the anti-PD-1 treatmentTRANSLATIONAL CANCER RESEARCH, 2024, 13 (08) : 4052 - 4061Zhuang, WeixiaWang, MoufengJiang, LiSu, ZudongLin, Shenglu
- [24] Gene expression profiles of peripheral blood mononuclear cells from patients with advanced non-small cell lung cancer treated with anti-PD-1 monoclonal antibodies.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Wu, JieCheung, Yee HimHuang, WeihuaYin, ChanghongFallon, John T.Dimitrova, NevenkaFanucchi, Michael Paul
- [25] Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 113 (02): : 415 - 425Kim, Kyung HwanPyo, HongryullLee, HoyoungOh, DongryulNoh, Jae MyoungAhn, Yong ChanYoon, Hong InMoon, HyowonLee, JiyunPark, SehhoonJung, Hyun-AeSun, Jong-MuLee, Se-HoonAhn, Jin SeokPark, KeunchilKu, Bo MiAhn, Myung-JuShin, Eui-Cheol
- [26] Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancerCLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (11): : 2241 - 2249Rogado, JacoboPozo, FernandoTroule, KevinSanchez-Torres, Jose MiguelRomero-Laorden, NuriaMondejar, RebecaDonnay, OlgaBallesteros, AnabelPacheco-Barcia, VilmaAspa, JavierAl-Shahrour, FatimaAlfranca, ArantzazuColomer, Ramon
- [27] Predictive immunological markers of anti-PD-1/PD-L1 therapy efficacy in non-small cell lung cancerANNALS OF ONCOLOGY, 2021, 32 : S1382 - S1382Musaelyan, A. A.Lapin, S. V.Urtenova, M. A.Chistyakov, I. V.Nazarov, V. D.Akopov, A. L.Orlov, S. V.
- [28] Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancerScientific Reports, 10Sohyun HwangAh-Young KwonJu-Yeon JeongSewha KimHaeyoun KangJoonsuk ParkJoo-Hang KimOk Jin HanSun Min LimHee Jung An
- [29] Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancerSCIENTIFIC REPORTS, 2020, 10 (01)Hwang, SohyunKwon, Ah-YoungJeong, Ju-YeonKim, SewhaKang, HaeyounPark, JoonsukKim, Joo-HangHan, Ok JinLim, Sun MinAn, Hee Jung
- [30] Nodal Immune Flare (NIF) Following Neoadjuvant Anti-PD-1 and Anti-CTLA-4 Therapy in Non-Small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S745 - S745Sepesi, B.Godoy, M.William, W.Vaporciyan, A.Lin, H.Leung, C.Lee, J.Mitchell, K.Weissferdt, A.Le, X.Lam, V.Fossella, F.Swisher, S.Heymach, J.Cascone, T.